Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$21,662,139
in 5 filings, $21.7M under 10b5-1 plans

Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-27 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sale 10b5-1 −2,984 $49.55 $148K 141,911
2023-02-27 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion · Option to Purchase Common Stock 10b5-1 −2,984 37,505
2023-02-27 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sale −7,016 $49.55 $348K 141,911
2023-02-27 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sale −2,984 $49.55 $148K 138,927
2023-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion +6,112 151,805
2023-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sale −2,878 $49.26 $142K 148,927
2023-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion · Restricted Stock Units −6,112 18,336
2023-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Grant or award · Option to Purchase Common Stock +48,849 48,849
2023-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Grant or award · Restricted Stock Units +17,053 17,053
2023-02-16 Snyder Mark Howard SVP, GENERAL COUNSEL Grant or award · Option to Purchase Common Stock +54,955 54,955
2023-02-16 Snyder Mark Howard SVP, GENERAL COUNSEL Grant or award · Restricted Stock Units +19,184 19,184
2023-02-16 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Exercise or conversion +5,094 11,591
2023-02-16 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Sale −2,525 $49.26 $124K 9,066
2023-02-16 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Exercise or conversion · Restricted Stock Units −5,094 15,279
2023-02-16 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Grant or award · Option to Purchase Common Stock +61,061 61,061
2023-02-16 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Grant or award · Restricted Stock Units +21,316 21,316
2023-02-16 Torley Helen PRESIDENT AND CEO Exercise or conversion +21,010 644,727
2023-02-16 Torley Helen PRESIDENT AND CEO Sale −11,061 $49.26 $545K 633,666
2023-02-16 Torley Helen PRESIDENT AND CEO Exercise or conversion · Restricted Stock Units −21,010 63,027
2023-02-16 Torley Helen PRESIDENT AND CEO Grant or award · Option to Purchase Common Stock +193,360 193,360

Page 40 of 48 · 944 trades